Gland Pharma reported a 6.7% year-on-year (YoY) growth in net profit for Q3 FY25, at ₹204.7 crore, compared to ₹191.9 crore ...

In the 8-infrastructure core sector basket, the maximum weightage is cornered by refinery products at 28.04%, followed by ...

The proposal was presented to the government of AP by HMPL, after which the latter sought a DPR from the company for further ...

HSBC Financial Services Fund offers an opportunity to take a thematic position in the fast growing financial services segment ...